Open J Gate, Genamik, Google Gelehrte, ISA (Indische wissenschaftliche Zusammenfassungen), CAS Datenbank (Chemische abstrakte Dienstleistungen), CABI (UK), Index Copernicus, Hinari, EBSCO, Ulrich's Periodicals Directory, Botanical Pesticides, Weed Abstracts, AgBiotechNet, VetMed Ressource , Abstracts zur Pflanzenphysiologie, Abstracts zur Agroforstwirtschaft, Abstracts zur Helminthologie, Ziergartenbau, Abstracts zu pflanzengenetischen Ressourcen, Nachrichten und Informationen zu Schweinen, Abstracts zur Milchwissenschaft, Datenbank für Agrarökonomie, Datenbank zur Parasitologie, CAB-Abstracts, Zoologische Aufzeichnungen, Nachrichten und Informationen nach der Ernte, Ernährungs- und Lebensmittelwissenschaften Datenbank, Organische Forschung Datenbank, Globale Gesundheit, ABC Chemie,Wissenschaftszentrale und SCIMAGO sind in der Bearbeitung vieler weiterer.
Nitin M Kadam
QbD has stirred pharma world w.r.t. new product filings and compliance. Enforcement of QbD in pharmaceutical development and continuing with product life cycle management has br..Mehr sehen»
Jonathan T. Grossman
As the list of neurological sequelae of Severe Acute Respiratory Syndrome Coronavirus 2. (SARS-CoV-2) infection continues to expand; the number of recorded cases of post-acute C..Mehr sehen»
Ayo Amarachi
Warm examination involves a gathering of strategies where a physical property of a substance is estimated to a controlled temperature program. One of the warm investigation proc..Mehr sehen»
Nicoline Schiess, Kathryn Brown Holroyd, Faisal Aziz Abdul Aziz, Katherine Huether, Miklos Szolics and Taoufik Alsaadi
The past 6 years have demonstrated a dramatic change in the landscape of immunomodulatory treatment for multiple sclerosis. Prior to 2010, there were no approved FDA oral immuno..Mehr sehen»
Neil M Renwick, Lev G Goldfarb, Nyamkhishig Sambuughin, Jenny E Hinshaw, Camilo Toro5 and Fyodor A Platonov
Mutations in dynamin-2 are associated with several neuromuscular disorders, including two forms of Charcot- Marie-Tooth disease, axonal CMT2M and intermediate CMTDIB, Centronucl..Mehr sehen»
Michael Har-Noy
Immunotherapy is now accepted as a new treatment modality for cancer. US FDA approved checkpoint blockage, anti-
CTLA4 and anti-PD1/L1, monoclonal antibody drugs and auto..Mehr sehen»